Klabax

Clarithromycin, the active ingredient in Klabax, is a macrolide antibiotic presented as an oral tablet for oral use. It treats bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, acute exacerbations of chronic bronchitis, skin and soft‑tissue infections, and is used in Helicobacter pylori eradication regimens.

GNH USA supplies Klabax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin acts against a broad range of bacteria and is used for several common infections. - Community‑acquired pneumonia: eradicates the causative pathogens and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute exacerbations of chronic bronchitis: diminishes bacterial load and eases breathing difficulties. - Skin and soft‑tissue infections: eliminates skin‑associated bacteria and promotes healing. - Helicobacter pylori eradication (in combination therapy): contributes to bacterial clearance as part of a multi‑drug regimen.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: frequent loose stools. - Abdominal pain: cramping or discomfort. - Altered taste: metallic or bitter sensation. - Headache: mild to moderate. - Vomiting: occasional episodes.

Serious or Rare Side Effects: - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - QT interval prolongation: risk of cardiac arrhythmias. - Clostridioides difficile colitis: severe diarrhea with abdominal pain. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Cardiac arrhythmias: palpitations or irregular heartbeat.

Before prescribing Clarithromycin, clinicians should consider several safety factors. - Renal impairment: assess kidney function and adjust dose if necessary. - Hepatic impairment: use with caution in patients with liver disease. - Cardiac risk: avoid in patients with known QT prolongation or arrhythmias. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Clarithromycin interacts with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Statins (e.g., simvastatin, lovastatin): increased risk of myopathy. - Certain antiarrhythmics (e.g., amiodarone): heightened QT prolongation. - Ergot derivatives: risk of ergot toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, monitor INR. - Oral hypoglycemics (e.g., sulfonylureas): possible hypoglycemia, monitor blood glucose.